 | Up a level |
Amstutz, Ursula; Mlakar, Vid; Curtis, Patricia Huezo-Diaz; Samer, Caroline; Baumann, Pierre; Bühlmann, Roland P; Meier-Abt, Peter; Meyer, Urs A; van Schaik, Ron H N; Ansari, Marc; Swiss Group of Pharmacogenomics and Personalised Therapy, SPT (2017). Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT). Drug metabolism and personalized therapy, 32(4), pp. 173-174. De Gruyter 10.1515/dmpt-2017-0033
Amstutz, Ursula; Grob, Tobias; Largiadèr, Carlo Rodolfo; Vassella, Erik (2017). Liquid Biopsy: Tumorgenetik in Körperflüssigkeiten. Pipette - Swiss laboratory medicine(6), pp. 11-12. EMH Schweizerischer Ärzteverlag AG
Amstutz, Ursula; Sokol, Lena; Vassella, Erik (2017). Liquid Biopsies in the personalized therapy of cancer patients. Schweizer Krebsbulletin / Bulletin suisse du cancer, 37(1), pp. 36-38. Istituto oncologico della Svizzera Italiana
Ambrodji, Alisa; Sadlon, Angélique; Amstutz, Ursula; Hoch, Dennis; Berger, Martin D.; Bastian, Sara; Offer, Steven M; Largiadèr, Carlo R. (2024). Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International journal of molecular sciences, 25(14) MDPI 10.3390/ijms25147599
Kueng, Nicholas; Sidler, Daniel; Banz, Vanessa; Largiadèr, Carlo R; Ng, Charlotte K Y; Amstutz, Ursula (2023). Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis. Diagnostics, 13(15) MDPI 10.3390/diagnostics13152505
Gallon, John; Rodríguez-Calero, Antonio; Benjak, Andrej; Akhoundova, Dilara; Maletti, Sina; Amstutz, Ursula; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; Bubendorf, Lukas; Moch, Holger; Thalmann, George; Feng, Felix Y; Gillessen, Silke; ... (2023). DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. Cancer research, 83(8), pp. 1203-1213. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-22-2236
Knappskog, Stian; Grob, Tobias; Venizelos, Andreas; Amstutz, Ursula; Hjortland, Geir O; Lothe, Inger M; Kersten, Christian; Hofsli, Eva; Sundlöv, Anna; Elvebakken, Hege; Garresori, Herish; Couvelard, Anne; Svensson, Johanna; Sorbye, Halfdan; Perren, Aurel (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO precision oncology, 7, e2200336. American Society of Clinical Oncology 10.1200/PO.22.00336
Lumish, Melissa; Thackray, Jennifer; Do, Richard Kinh Gian; Caudle, Kelly E; Amstutz, Ursula; Schwab, Matthias; Diasio, Robert B; Jarnagin, William R; Cercek, Andrea (2023). Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine. JCO precision oncology, 7(e2200442), e2200442. American Society of Clinical Oncology 10.1200/PO.22.00442
Kueng, Nicholas; Arcioni, Séverine; Sandberg, Fanny; Kuhn, Christian; Banz, Vanessa; Largiadèr, Carlo R; Sidler, Daniel; Amstutz, Ursula (2023). Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients. Frontiers in genetics, 14(1089830), p. 1089830. Frontiers Media SA 10.3389/fgene.2023.1089830
Born, Alexander; Bocchi, Federica; Kuhn, Christian; Amstutz, Ursula; Baumgartner, Markus R; Sidler, Daniel (2023). Tacrolimus monitoring in hair samples of kidney transplant recipients. Frontiers in medicine, 10(1307505), p. 1307505. Frontiers 10.3389/fmed.2023.1307505
Rodriguez-Calero, Antonio; Gallon, John; Akhoundova, Dilara; Maletti, Sina; Ferguson, Alison; Cyrta, Joanna; Amstutz, Ursula; Garofoli, Andrea; Paradiso, Viola; Tomlins, Scott A; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Vassella, Erik; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; ... (2022). Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nature Communications, 13(1), p. 2400. Springer Nature 10.1038/s41467-022-30003-5
Begré, Ursina B M; Jörger, Markus; Aebi, Stefan; Amstutz, Ursula; Largiadèr, Carlo R (2022). Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland. Frontiers in Pharmacology, 13, p. 885259. Frontiers 10.3389/fphar.2022.885259
Meihandoest, Tamana; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Amstutz, Ursula; Bovet, Cedric; Sauter, Thomas C; Asmis, Lars M; Nagler, Michael (2022). Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. Frontiers in cardiovascular medicine, 9, p. 817826. Frontiers 10.3389/fcvm.2022.817826
Hamzic, Seid; Schärer, Dominic; Offer, Steven M.; Meulendijks, Didier; Nakas, Christos; Diasio, Robert B; Fontana, Stefano; Wehrli, Marc; Schürch, Stefan; Amstutz, Ursula; Largiadèr, Carlo R. (2021). Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity. British journal of clinical pharmacology, 87(8), pp. 3234-3243. Wiley-Blackwell 10.1111/bcp.14742
Hamzic, Seid; Aebi, Stefan; Joerger, Markus; Montemurro, Michael; Ansari, Marc; Amstutz, Ursula; Largiadèr, Carlo (2020). Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy. Swiss medical weekly, 150, w20375. EMH Media 10.4414/smw.2020.20375
Cismaru, Anca Liliana; Rudin, Deborah; Ibañez, Luisa; Liakoni, Evangelia; Bonadies, Nicolas; Kreutz, Reinhold; Carvajal, Alfonso; Lucena, Maria Isabel; Martin, Javier; Sancho Ponce, Esther; Molokhia, Mariam; Eriksson, Niclas; EuDAC, Collaborators; Krähenbühl, Stephan; Largiadèr, Carlo R.; Haschke, Manuel Martin; Hallberg, Pär; Wadelius, Mia; Amstutz, Ursula (2020). Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations. Genes, 11(11) MDPI 10.3390/genes11111275
Schaerer, Dominic; Froehlich, Tanja K.; Hamzic, Seid; Offer, Steven M.; Diasio, Robert B.; Joerger, Markus; Amstutz, Ursula; Largiadèr, Carlo R. (2020). A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. Journal of personalized medicine, 10(4) MDPI 10.3390/jpm10040181
Hamzic, Seid; Kummer, Dominic; Froehlich, Tanja K.; Joerger, Markus; Aebi, Stefan; Palles, Claire; Thomlinson, Ian; Meulendijks, Didier; Schellens, Jan H M; García-González, Xandra; López-Fernández, Luis A; Amstutz, Ursula; Largiadèr, Carlo R. (2020). Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Pharmacological research, 152, p. 104594. Elsevier 10.1016/j.phrs.2019.104594
Cismaru, Anca Liliana; Grimm, Livia; Rudin, Deborah; Ibañez, Luisa; Liakoni, Evangelia; Bonadies, Nicolas; Kreutz, Reinhold; Hallberg, Pär; Wadelius, Mia; Haschke, Manuel; Largiadèr, Carlo R.; Amstutz, Ursula (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis. Frontiers in genetics, 11(951), p. 951. Frontiers Media SA 10.3389/fgene.2020.00951
Rudin, Deborah; Spoendlin, Julia; Cismaru, Anca L.; Liakoni, Evangelia; Bonadies, Nicolas; Amstutz, Ursula; Meier, Christoph R; Krähenbühl, Stephan; Haschke, Manuel (2019). Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients. European journal of internal medicine, 68, pp. 36-43. Elsevier 10.1016/j.ejim.2019.07.029
Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Novak, Urban; Gfeller, Eva; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & lymphoma, 60(10), pp. 2588-2590. Taylor & Francis 10.1080/10428194.2019.1585838
Wright, Galen E B; Amstutz, Ursula; Drögemöller, Britt I; Shih, Joanne; Rassekh, Shahrad R; Hayden, Michael R; Carleton, Bruce C; Ross, Colin J D (2019). Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes. Clinical pharmacology and therapeutics, 105(2), pp. 402-410. Wiley 10.1002/cpt.1179
Drögemöller, Britt I; Wright, Galen E B; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin J D; Amstutz, Ursula; Carleton, Bruce C (2019). CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines. Breast cancer research and treatment, 173(3), pp. 521-532. Springer 10.1007/s10549-018-5027-0
Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Angelillo, Anne; Trümper, Lorenz; Fiedler, Georg Martin; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology, 37(3), pp. 319-322. Wiley 10.1002/hon.2603
Bacher, Vera Ulrike; Shumilov, Evgenii; Flach, Johanna; Porret, Naomi; Joncourt, Raphael; Wiedemann, Gertrud; Fiedler, Martin; Novak, Urban; Amstutz, Ursula; Pabst, Thomas (2018). Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood cancer journal, 8(11), p. 113. Nature Publishing Group 10.1038/s41408-018-0148-6
Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Genotype-guided fluoropyrimidine dosing: ready for implementation. The lancet oncology, 19(11), pp. 1421-1422. Elsevier 10.1016/S1470-2045(18)30744-7
Hamzic, Seid; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy? Pharmacogenomics, 19(8), pp. 689-692. Future Medicine 10.2217/pgs-2018-0040
Smy, Laura; Shaw, Kaitlyn; Amstutz, Ursula; Staub, Michelle; Chaudhry, Shahnaz; Smith, Anne; Carleton, Bruce; Koren, Gideon (2018). Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study. Clinical biochemistry, 56, pp. 26-32. Elsevier 10.1016/j.clinbiochem.2018.04.006
Amstutz, Ursula; Schärer, Dominic Manuel; Andrey, G; Wirthmüller, Urs; Largiadèr, Carlo Rodolfo (2018). An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51. HLA : immune response genetic, 92(2), pp. 90-93. Wiley 10.1111/tan.13296
Amstutz, Ursula; Henricks, Linda M; Offer, Steven M; Barbarino, Julia; Schellens, Jan H M; Swen, Jesse J; Klein, Teri E; McLeod, Howard L; Caudle, Kelly E; Diasio, Robert B; Schwab, Matthias (2018). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Clinical pharmacology and therapeutics, 103(2), pp. 210-216. Wiley 10.1002/cpt.911
Drögemöller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin J D; Gelmon, Karen A; ... (2017). Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA oncology, 3(11), pp. 1558-1562. American Medical Association 10.1001/jamaoncol.2017.0502
Baumann, Pierre; Amstutz, Ursula; Bühlmann, Roland P; Meier-Abt, Peter; Meyer, Urs A; Samer, Caroline; Ansari, Marc (2017). Pharmacogénomique et thérapie personnalisée. Revue médicale suisse, 13(573), pp. 1544-1545. Médecine & Hygiène
Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Rieder, Michael J; Bhavsar, Amit P; Sanatani, Shubhayan; Bernstein, Daniel; Hayden, Michael R; Amstutz, Ursula; Carleton, Bruce C (2017). Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer. British journal of clinical pharmacology, 83(5), pp. 1143-1145. Wiley-Blackwell 10.1111/bcp.13218
Hamzic, Seid; Wenger, N; Fröhlich, Tanja; Joerger, M; Aebi, Stefan; Largiadèr, Carlo Rodolfo; Amstutz, Ursula (2017). The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity. Pharmacogenomics journal, 17(4), pp. 319-324. Nature Publishing Group 10.1038/tpj.2016.23
Hamzic, Seid; Kummer, Dominic; Milesi, S; Mueller, D; Joerger, M; Aebi, S; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2017). Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity. Clinical pharmacology & therapeutics, 102(5), pp. 796-804. Wiley 10.1002/cpt.641
Smy, Laura; Shaw, Kaitlyn; Amstutz, Ursula; Smith, Anne; Berger, Howard; Carleton, Bruce; Koren, Gideon (2016). Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study. BMC pregnancy and childbirth, 16(1)(176), p. 176. BioMed Central 10.1186/s12884-016-0962-4
Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Hwang, Soomi; Rieder, Michael J; Bhavsar, Amit P; Smith, Anne; Sanatani, Shubhayan; Gelmon, Karen A; Bernstein, Daniel; Hayden, Michael R; Carleton, Bruce C; Amstutz, Ursula (2016). Recommendations for Genetic Testing to Reduce the Incidence of Anthracycline-induced Cardiotoxicity. British journal of clinical pharmacology, 82(3), pp. 683-695. Wiley-Blackwell 10.1111/bcp.13008
Lee, Jong W; Pussegoda, Kusala; Rassekh, Rod S; Monzon, Jose G; Liu, Geoffrey; Hwang, Soomi; Bhavsar, Amit P; Pritchard, Sheila; Ross, Colin J; Carleton, Bruce C; Amstutz, Ursula (2016). Clinical Practice Recommendations For The Management And Prevention Of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers. Therapeutic drug monitoring, 38(4), p. 1. Lippincott Williams & Wilkins 10.1097/FTD.0000000000000298
Meulendijks, D; Henricks, LM; Amstutz, Ursula; Fröhlich, Tanja; Largiadèr, Carlo Rodolfo; Beijnen, JH; de Boer, A; Deenen, MJ; Cats, A; Schellens, JHM (2016). Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity. International journal of cancer, 138(11), pp. 2752-2761. Wiley-Blackwell 10.1002/ijc.30014
Meulendijks, Didier; Henricks, Linda M.; Sonke, Gabe S.; Deenen, Maarten J.; Froehlich, Tanja K.; Amstutz, Ursula; Largiadèr, Carlo R.; Jennings, Barbara A.; Marinaki, Anthony M.; Sanderson, Jeremy D.; Kleibl, Zdenek; Kleiblova, Petra; Schwab, Matthias; Zanger, Ulrich M; Palles, Claire; Tomlinson, Ian; Gross, Eva; van Kuilenburg, André B. P.; Punt, Cornelis J. A.; Koopman, Miriam; ... (2015). Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. The lancet oncology, 16(16), pp. 1639-1650. Elsevier 10.1016/S1470-2045(15)00286-7
Aminkeng, Folefac; Bhavsar, Amit P; Visscher, Henk; Rassekh, Shahrad R; Li, Yuling; Lee, Jong W; Brunham, Liam R; Caron, Huib N; van Dalen, Elvira C; Kremer, Leontien C; van der Pal, Helena J; Amstutz, Ursula; Rieder, Michael J; Bernstein, Daniel; Carleton, Bruce C; Hayden, Michael R; Ross, Colin J D (2015). A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nature genetics, 47(9), pp. 1079-1084. Nature America 10.1038/ng.3374
Shaw, Kaitlyn; Amstutz, Ursula; Kim, Richard B; Lesko, Lawrence J; Turgeon, Jacques; Michaud, Veronique; Hwang, Soomi; Ito, Shinya; Ross, Colin; Carleton, Bruce C (2015). Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Therapeutic drug monitoring, 37(4), pp. 428-436. Lippincott Williams & Wilkins 10.1097/FTD.0000000000000192
Kummer, Dominic; Fröhlich, Tanja; Joerger, Markus; Aebi, Stefan; Sistonen, Johanna; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2015). Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. Pharmacogenomics, 16(12), pp. 1367-1377. Future Medicine 10.2217/pgs.15.81
Jiménez-Triana, Clímaco Andres; Castelán-Martínez, Osvaldo D.; Rivas-Ruiz, Rodolfo; Jiménez-Méndez, Ricardo; Medina, Aurora; Clark, Patricia; Rassekh, Rod; Castañeda-Hernández, Gilberto; Carleton, Bruce; Medeiros, Mara; Amstutz, Ursula; Canadian Pharmacogenomics Network for Drug Safety Consortium, CPNDS (2015). Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study. Medicine, 94(34), e1413. Lippincott Williams & Wilkins 10.1097/MD.0000000000001413
Visscher, Henk; Rassekh, S Rod; Sandor, George S; Caron, Huib N; van Dalen, Elvira C; Kremer, Leontien C; van der Pal, Helena J; Rogers, Paul C; Rieder, Michael J; Carleton, Bruce C; Hayden, Michael R; Ross, Colin J; Amstutz, Ursula; Canadian Pharmacogenomics Network for Drug Safety consortium, CPNDS (2015). Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics, 16(10), pp. 1065-1076. Future Medicine 10.2217/pgs.15.61
Amstutz, Ursula; Offer, Steven M; Sistonen, Johanna; Joerger, Markus; Diasio, Robert B; Largiadèr, Carlo Rodolfo (2015). Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy. Clinical cancer research, 21(9), pp. 2038-2044. American Association for Cancer Research 10.1158/1078-0432.CCR-14-2817
Fröhlich, Tanja; Amstutz, Ursula; Aebi, Stefan; Joerger, Markus; Largiadèr, Carlo Rodolfo (2015). Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity. International journal of cancer, 136(3), pp. 730-739. Wiley-Blackwell 10.1002/ijc.29025
Shaw, Kaitlyn; Amstutz, Ursula; Hildebrand, Claudette; Rassekh, S Rod; Hosking, Martin; Neville, Kathleen; Leeder, J Steven; Hayden, Michael R; Ross, Colin J; Carleton, Bruce C (2014). VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children. Pediatric blood & cancer, 61(6), pp. 1055-1062. Wiley-Liss 10.1002/pbc.24932
Amstutz, Ursula; Shear, Neil H; Rieder, Michael J; Hwang, Soomi; Fung, Vincent; Nakamura, Hidefumi; Connolly, Mary B; Ito, Shinya; Carleton, Bruce C (2014). Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia, 55(4), pp. 496-506. Wiley-Blackwell 10.1111/epi.12564
Amstutz, Ursula; Farese, Simone; Aebi, Stefan; Largiadèr, Carlo R (2008). Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy. Clinical cancer research, 27(1), p. 54. Philadelphia, Pa.: American Association for Cancer Research 10.1186/1756-9966-27-54
Giger, Thomas; Excoffier, Laurent; Amstutz, Ursula; Day, Philip J R; Champigneulle, Alexis; Hansen, Michael M; Kelso, Janet; Largiadèr, Carlo R (2008). Population transcriptomics of life-history variation in the genus Salmo. Molecular Ecology, 17(13), pp. 3095-3108. Oxford: Wiley-Blackwell 10.1111/j.1365-294X.2008.03820.x
